Inflammatory mediators as biomarkers in brain disorders

Area of Science:

• Neuroscience
• Immunology
• Biomarker Discovery

Background:

• Neurodegenerative diseases (NDs) like Alzheimer's and Parkinson's are characterized by progressive neuron death and are currently incurable.
• Accurate diagnosis is challenging due to difficulties in obtaining pathological confirmation via biopsies.
• Inflammation is a common feature in NDs, suggesting its potential role in biomarker development.

Purpose of the Study:

• To review and summarize key inflammation biomarkers for neurodegenerative diseases.
• To highlight the potential of these biomarkers in disease identification, monitoring, and treatment evaluation.

Main Methods:

• Literature review of current inflammation biomarkers relevant to neurodegenerative diseases.
• Analysis of biomarker characteristics, including measurability, reproducibility, and specificity.

Main Results:

• Several inflammation biomarkers show promise for neurodegenerative disease management.
• The ideal biomarker must be easily measurable, reproducible, and population-stable.

Conclusions:

• Inflammation biomarkers offer a viable strategy for improving the diagnosis and monitoring of neurodegenerative diseases.
• Validated biomarkers can assist in tracking disease phases and therapeutic responses.